Amundi, Others Get $1.14 Billion From Singapore Central Bank to Bolster Stock Market
By Megan Cheah
SINGAPORE--Singapore's central bank has appointed five more asset managers, including Amundi, under efforts to boost liquidity in the city-state's equity market.
These managers will have access to 1.45 billion Singapore dollars, equivalent to US$1.14 billion, with the appointed managers, the Monetary Authority of Singapore said Tuesday.
These are France's Amundi, California-based Franklin Templeton, the asset-management arm of British-domiciled lender HSBC, London-based M&G Investments and Natixis Investment Managers, an asset-management firm under France's Groupe BPCE.
The funds are part of S$6.5 billion set aside by the MAS under its equity-market development program to boost the local stock market, following an assessment of Singapore's stock market.
The new tranche of funds brings the total allocations under the program to S$5.4 billion across 14 asset managers. Other companies previously appointed include BlackRock and Prudential PLC's Eastspring Investments.
The MAS said it is reviewing proposals for a fourth batch of fund managers and expects to complete this review next year.
The central bank concurrently announced it was committing S$20 million to support "market-making activities" in eligible Singapore-listed stocks until end-2028, such as boosting the trading liquidity of certain small- and mid-cap stocks, and new listings.
Singapore's stock market had been undergoing a gradual revival thanks to government-linked support, including the central bank-led development program. The benchmark FTSE Straits Times Index has notched new highs in the past months, despite volatility from geopolitical tensions and investors' shifting sentiment on risk assets.
Fresh fund allocations from the program are likely to support stronger securities turnover trends in the city-state's stock exchange, Macquarie Capital said in a recent report.
Write to Megan Cheah at megan.cheah@wsj.com
(END) Dow Jones Newswires
September 28, 2026 23:34 ET (03:34 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
4 Stocks to Buy Before They Rise Further
2 Undervalued Stocks to Buy Before They Rebound
The 10 Best Companies to Invest in Now
The 10 Best Dividend Stocks
